StarProofed
Jaroslavs Pihtovs
Archbishop Riordan Crusaders

Jaroslavs Pihtovs

Basketball · Power Forward · Class of 2026 · 3-star
Total Brand Value
Not public
Social Media Value
Not public
Est. NIL Value
Not public
Recruiting Rank
Natl #132
Height / Weight
6-9 · 215
Hometown
San Francisco, CA
Claim Profile
Updated Jun 10, 2026Estimated

About Jaroslavs

Jaroslavs Pihtovs is a power forward in the class of 2026 who plays at Archbishop Riordan in San Francisco, CA. A 3-star recruit, he is ranked No. 132 nationally and No. 20 at his position, and No. 16 in his state. He is listed at 6-9 and 215 pounds.

Scouting Report

Scouting report is not available currently.

NIL / Brand

NIL / Brand report is not available currently.

Recruiting Profile

Status
Committed
Rankings
Stars
★★★
National
#132
Position
#20
State
#16
Reported Team Interest
University of San Francisco · Committed
Methodology

How Jaroslavs's Brand Value Is Calculated

A public NIL valuation is not available for Jaroslavs Pihtovs. Financial terms of NIL activity are often private.

Frequently Asked Questions

What is Jaroslavs Pihtovs's NIL value?+

Jaroslavs Pihtovs does not have a publicly available NIL valuation at this time. NIL compensation is often private, and estimates are only published for players with sufficient public data.

What school does Jaroslavs Pihtovs play for?+

Jaroslavs Pihtovs plays at Archbishop Riordan and is a class of 2026 recruit. He has not publicly committed to a college program.

What position does Jaroslavs Pihtovs play?+

Jaroslavs Pihtovs plays power forward (PF) and is ranked No. 20 nationally at the position.

Where is Jaroslavs Pihtovs from?+

Jaroslavs Pihtovs is from San Francisco, CA and attended Archbishop Riordan.

How is Jaroslavs Pihtovs ranked as a recruit?+

Jaroslavs Pihtovs is rated a 3-star recruit, ranked No. 132 nationally in his class and No. 16 in his state.

NIL values shown are estimates based on publicly available information, including social reach and reported partnerships — they are not confirmed compensation. Reported deals are based on public sources; financial terms of most deals are not publicly disclosed. Estimated values originate from On3's published NIL valuation.